Versant Capital Management, Inc - GLOBAL BLOOD THERAPEUTICS IN ownership

Back to all holdings Add to watchlist

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 259 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2020. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Links
Filings
EDGAR links
External links
Quarter-by-quarter ownership
Versant Capital Management, Inc ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q4 2020$0–130.0%0.00%–
Q3 2020$0–13
-13.3%
0.00%–
Q2 2020$0–150.0%0.00%–
Q1 2020$0
-100.0%
150.0%0.00%
-100.0%
Q4 2019$1,000–150.0%0.00%–
Q3 2019$0–15
+150.0%
0.00%–
Q1 2019$0–6–0.00%–
 Download
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2020
NameSharesValueWeighting ↓
HUNTINGTON NATIONAL BANK 1$680.00%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders